MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions.

Familial Cancer
Jeremie H LefevreYann Parc

Abstract

MYH associated polyposis is a hereditary syndrome responsible for early colorectal cancer with a distinct genetic pathway from the Familial Adenomatous Polyposis or the Hereditary Non Polyposis Colorectal Cancer syndrome. We have studied a family with three members bearing a biallelic mutation in MYH at c.1185_1186dup. One patient who developed colon cancer had loss of expression of MLH1 on tumoral tissue and microsatellite instability (MSI) phenotype. Analysis of MLH1 based on his blood sample revealed no germline mutation or large genomic deletion. No methylation of the promoter was identified in tumoral DNA. No transversion mutations were identified in APC or KRAS in tumor DNA of this patient. Loss of expression of MLH1 was due to a transversion in intron 7 at position +5 (c.588 + 5G > T) leading to a complete deletion of exon 7 at the RNA level. This observation demonstrates that MLH1 can be a target of MYH transversions leading to MSI phenotype.

References

Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jan 31, 2002·Nature Genetics·Nada Al-TassanJeremy P Cheadle
Jun 14, 2002·Current Biology : CB·Claudia ColussiMargherita Bignami
Nov 26, 2003·Mutation Research·Geir SlupphaugHans E Krokan
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Guoren DengYoung S Kim
Sep 3, 2004·Journal of Medical Genetics·E DomingoS Schwartz
Oct 6, 2005·International Journal of Cancer. Journal International Du Cancer·Brigitte WolfJudith Karner-Hanusch
Dec 13, 2005·Human Genetics·Constanze PagenstecherElisabeth Mangold
Nov 24, 2006·Annals of Surgery·Jérémie H LefevreYann R Parc

❮ Previous
Next ❯

Citations

May 12, 2012·The Journal of Biological Chemistry·Katherine A DoniganJoann B Sweasy
Mar 20, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M SerenoE Casado Sáenz
Jun 24, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Adela CastillejoJosé Luis Soto
Feb 13, 2014·European Journal of Human Genetics : EJHG·Monika MorakElke Holinski-Feder
Sep 19, 2012·Familial Cancer·Isabelle SourrouilleFlorent Soubrier
Nov 6, 2014·European Journal of Human Genetics : EJHG·Fadwa A ElsayedTom van Wezel
Nov 22, 2016·The American Journal of Dermatopathology·Denisa KacerovskaDmitry V Kazakov
Jun 26, 2013·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Rabeah Abbas Al-TemaimiFahd Al-Mulla
Jul 11, 2018·International Journal of Cancer. Journal International Du Cancer·Katrin KayserVerena Steinke-Lange
May 6, 2016·Diseases of the Colon and Rectum·James Church, Sara Kravochuck
Apr 4, 2012·Diseases of the Colon and Rectum·James ChurchMatt Kalady
Aug 1, 2012·The Cancer Journal·Kristen Mahoney Shannon, Anu Chittenden
Jan 10, 2021·Diagnostics·Megan L HutchcraftJill M Kolesar
Mar 3, 2020·Journal of Visceral Surgery·B MenahemC Sabbagh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

© 2021 Meta ULC. All rights reserved